Increased non-transferrin bound iron in plasma-depleted SAG-M red blood cell units

Vox Sanguinis

Volumn 82, Issue 3, 2002, Pages 122-126

  Marwah, S S ^a   Blann, A ^a   Harrison, P ^a   Lumley, M A ^b   Wright, J ^a   McDowell, J ^a   Phillips, J D ^c   Rea, C ^c   Bareford, D ^a  

^a CITY HOSPITAL   (United Kingdom)

^b Regional Blood Transfusion Service   (United Kingdom)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Bacterial contamination; Fresh frozen plasma; Iron overload; Non transferrin bound iron (NTBI); Platelets; SAG M

Indexed keywords

ADENINE; BLEOMYCIN; FRESH FROZEN PLASMA; GLUCOSE; IRON; MANNITOL; NON TRANSFERRIN BOUND IRON; SODIUM CHLORIDE; THROMBOCYTE CONCENTRATE; TRANSFERRIN; UNCLASSIFIED DRUG; PLASMA SUBSTITUTE; SAG M BLOOD; SAG-M BLOOD;

ARTICLE; ASSAY; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BLOOD DONOR; BLOOD STORAGE; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROCYTE; HEMOGLOBINOPATHY; HEMOLYSIS; HUMAN; HUMAN CELL; IRON OVERLOAD; PLASMA; PRIORITY JOURNAL; THROMBOCYTE; CHEMISTRY; ERYTHROCYTE TRANSFUSION; METHODOLOGY; PHYSIOLOGY; TIME;

BACTERIAL INFECTIONS; BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; IRON OVERLOAD; PLASMA SUBSTITUTES; TIME FACTORS; TRANSFERRIN;

EID: 0036551122     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2002.00153.x     Document Type: Article

References (23)

1. Prati D: Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major. Vox Sang 2000; 79:129-137
2. Al-Refaie FN, Wickens DG, Wonke GJ, Kontoghiorghes GJ, Hoffbrand AV: Serum non-transferrin bound iron in beta thalassaemia major patients treated with desferrioxamine and L1. Br J Haematol 1992; 82:431-436
3. Harrison P, Marwah S, Hughes RT, Bareford D: Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy. J Clin Pathol 1994; 47:350-352
4. Hoen B: Iron and infection: clinical experience. Am J Kidney Dis 1999; 34:s30-s34
5. Vichinsky EP: Current issues with blood transfusions in sickle cell disease. Semin Hematol 2001; 38:14-22
6. McDonald CP, Barbara AJ, Hewitt PE, Hartley S, Telfer P, Gale R, James E, Prentice HG: Yersinia enterocolitica transmission from a red cell unit 34 days old. Transfus Med 1996; 6:61-63
7. Bassett ML: Haemochromatosis: iron still matters. J Intern Med 2001; 31:237-242
8. Loreal O, Gosriwatana I, Guyader D, Porter J, Brissot P, Hider RC: Determination of non-transferrin bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 2000; 32:727-733
9. Harrison P, Neilson JR, Marwah S, Madden L, Bareford D, Milligan DW: Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation. J Clin Pathol 1996; 49:853-856
10. Gutteridge JMC, Yukying H: Iron complexes and their reactivity in the bleomycin assay for radical promoting loosely-bound iron. Free Radic Res Commun 1986; 2:43-151
11. Evans PJ, Halliwell B. Measurement of iron and copper in biological systems: bleomycin and copper-phenanthroline assays. Methods Enzymol 1994; 233:82-92
12. Anon: Guidelines for the Blood Transfusion Services in the UK, 4th edn. London, HMSO, 2000
13. Fontecave M, Pierre JL: Iron: metabolism, toxicity and therapy. Biochemmic 1993; 75:767-773
14. Caprari P, Tarzia A, Caforio MP, Maffi D, Pasqiuno MT, Salvati AM, Guiliani E, Martorana MC, Mannella E: Oxidative damage caused by in vitro ageing in red blood cells for transfusion. Hematol J 2000; 1:120
15. Otto BR, Verweij Vught AMJJ, Maclaren DM: Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit Rev Microbiol 1992; 18:217-233
16. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ: Non-transferring bound iron in plasma or serum from patients with idiopathic haemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 1989; 264:4417-4422
17. Sugiyama H, Yu C, Murugesan N, Hechet SM: Structure of alkali-liable product formed during iron (II)-bleomycin mediated DNA strand scission. J Am Chem Soc 1985; 107:4104-4105
18. Weinberg ED: Cellular iron metabolism in health and disease. Drug Metab Rev 1990; 22:531-535
19. Carbonetti NH, Boonchai S, Perry SH, Vaianen-Rhen V, Korhonen TK, Williams PH: Aerobactin-mediated iron uptake by Escherichia coli isolates from human extra intestinal infections. Infect Immun 1986; 51:966-968
20. Schubert S, Fisher D, Heeseman J: Ferric enterochelin transport in Yersinia enterocolitica: molecular and evolutionary aspects. J Bacteriol 1999; 181:6387-6395
21. Garcia-Erce JA, Solano VM, Seoane A, Giralt M: Bacterial contamination of blood components. Vox Sang 2000; 79:249-250
22. Anon: The 'SHOT' Annual Report 1999-2000. Oxford, UK, Blackwell Science Publication Ltd, 2001
23. Patruta SI, Edlinger R, Sunder-Plassmann G, Horl WH: Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 1998; 9:655-663